Compile Data Set for Download or QSAR
maximum 50k data
Found 10 of ic50 data for complexid = 320
TargetCytochrome P450 1A2/2C18/2C19(Homo sapiens (Human))
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM461264(US10774056, Compound 028 | US11542242, Compound 02...)
Affinity DataIC50:  5.90E+3nMAssay Description:For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 1A2/2C18/2C19(Homo sapiens (Human))
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM461268(US10774056, Compound 032 | US11542242, Compound 03...)
Affinity DataIC50:  9.50E+3nMAssay Description:For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 1A2/2C18/2C19(Homo sapiens (Human))
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM461258(US10774056, Compound 007 | US11542242, Compound 00...)
Affinity DataIC50: >1.00E+4nMAssay Description:For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 1A2/2C18/2C19(Homo sapiens (Human))
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM461260(US10774056, Compound 022 | US11542242, Compound 02...)
Affinity DataIC50: >1.00E+4nMAssay Description:For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 1A2/2C18/2C19(Homo sapiens (Human))
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM461263(US10774056, Compound 027 | US11542242, Compound 02...)
Affinity DataIC50: >1.00E+4nMAssay Description:For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 1A2/2C18/2C19(Homo sapiens (Human))
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM461266(US10774056, Compound 030 | US11542242, Compound 03...)
Affinity DataIC50: >1.00E+4nMAssay Description:For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 1A2/2C18/2C19(Homo sapiens (Human))
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM461267(US10774056, Compound 031 | US11542242, Compound 03...)
Affinity DataIC50: >1.00E+4nMAssay Description:For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 1A2/2C18/2C19(Homo sapiens (Human))
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM461257(US10774056, Compound 006 | US11542242, Compound 00...)
Affinity DataIC50: >1.00E+4nMAssay Description:For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 1A2/2C18/2C19(Homo sapiens (Human))
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM461256(US10774056, Compound 003 | US11542242, Compound 00...)
Affinity DataIC50: >1.00E+4nMAssay Description:For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 1A2/2C18/2C19(Homo sapiens (Human))
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM461261(US10774056, Compound 025 | US11542242, Compound 02...)
Affinity DataIC50: >1.00E+4nMAssay Description:For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent